A study involving 390 stage I–II BC patients with BRCA1/2 mutations demonstrated that women who received contralateral prophylactic mastectomy experienced a 48% reduction in the risk of mortality compared to those who underwent unilateral mastectomy [36]. The gene discussed is BRCA1; the disease is breast cancer.